PFA
AMGN icon

Pathway Financial Advisors’s Amgen AMGN Stock Holding History

Pathway Financial Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-671
Closed -$216K – 166
2024
Q3 		$216K Hold
671
– – 0.06% 154
2024
Q2 		$210K Buy
+671
New +$197K 0.06% 156
2022
Q4 		– Sell
-1,881
Closed -$424K – 126
2022
Q3 		$424K Buy
1,881
+324
+21% +$78.5K 0.15% 72
2022
Q2 		$379K Buy
+1,557
New +$382K 0.16% 73
2018
Q3 		– Sell
-571
Closed -$105K – 108
2018
Q2 		$105K Hold
571
– – 0.06% 153
2018
Q1 		$97K Sell
571
-34
-6% -$6.24K 0.06% 166
2017
Q4 		$105K Buy
+605
New +$107K 0.06% 152

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Pathway Financial Advisors's AMGN Position: Q4 2024 in Review

Pathway Financial Advisors sold out of Amgen (AMGN) in Q4 2024, closing a stake of 671 shares — an estimated $216K sold.

Pathway Financial Advisors first reported a position in AMGN in Q4 2017 and held it in 7 quarters. The position peaked at $424K in Q3 2022. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Pathway Financial Advisors reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • Pathway Financial Advisors sold 671 Amgen shares in Q4 2024, an estimated $216K.
  • Pathway Financial Advisors first reported a position in Amgen in Q4 2017 and held it in 7 quarters.
  • Pathway Financial Advisors's Amgen position peaked at $424K in Q3 2022.
  • 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Pathway Financial Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.